Literature DB >> 399720

Colonization by Salmonella typhimurium and Shigella flexneri III of the gastrointestinal tract of mice treated with beta-2-thienylalanine and streptomycin.

K J Brown, G W Tannock, R A Eyres, R B Elliott, D R Lines.   

Abstract

Mice fed beta-2-thienylalanine (beta-2-T) by oesophageal tube were no more susceptible to gastrointestinal tract colonization by Salmonella typhimurium or Shigella flexneri III than control mice fed water. In both beta-2-T-fed and water-fed groups, the increasing dosage of S. typhimurium, in logarithmic increments to groups of mice, resulted in increasing numbers of these bacteria detectable on dilution plates from organ homogenates. Colonization by S. flexneri III only occurred at a dosage of 10(8) bacteria for both groups. Pretreatment with 50 mg streptomycin allowed 10(3) Salmonella or 10(4) Shigella to colonize both beta-2-T and water-fed groups. Coliforms, inhibited by beta-2-T under certain conditions in vitro, were found in equal numbers in both groups. No obvious differences were noted in either types of other bacteria detected or numbers recovered from the two groups. No gross behavioural changes were noted in mice fed beta-2-T and not challenged with pathogenic bacteria, and no pathological changes were noted in hepatic or splenic tissues. With increasing Salmonella dosage, collections of polymorphonuclear leucocytes, which were almost focal, and increased numbers of giant cells were noted in splenic red pulp areas, in both groups.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 399720     DOI: 10.1007/bf00403653

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


  25 in total

1.  Effects of versene and beta-2-thienylalanine on the developing down feather.

Authors:  R J FABINY
Journal:  Am J Anat       Date:  1959-03

2.  Biochemical transformations as determined by competitive analogue-metabolite growth inhibitions; a transformation involving phenylalanine.

Authors:  E BEERSTECHER; W SHIVE
Journal:  J Biol Chem       Date:  1946-07       Impact factor: 5.157

3.  L-phenylalanine interactions with structurally related substances at the intestinal mucosa.

Authors:  R A Wapnir; F Lifshitz
Journal:  Biochem Med       Date:  1974-12

4.  Phenylketonuria: reduction of serum levels of phenylalanine following oral administration of B-2 thienylalanine.

Authors:  C Krips; D R Lines
Journal:  Aust Paediatr J       Date:  1972-12

5.  Effects of totally synthetic, low phenylalanine diet on adolescent phenylketonuric patients.

Authors:  C M McKean
Journal:  Arch Dis Child       Date:  1971-10       Impact factor: 3.791

6.  Effect of beta-2-thienylalanine on developing mouse tooth germs in vitro.

Authors:  E J Kollar; G R Baird
Journal:  J Dent Res       Date:  1968 May-Jun       Impact factor: 6.116

7.  The inhibition of intestinal absorption of phenylalanine in the rhesus monkey.

Authors:  D R Lines; H A Waisman
Journal:  Proc Soc Exp Biol Med       Date:  1970-12

8.  The antiphenylalanine effect of beta-2-thienylalanine for the rat.

Authors:  M F FERGER; V DU VIGNEAUD
Journal:  J Biol Chem       Date:  1949-05       Impact factor: 5.157

9.  Effects of changes in Mg++ ion concentration upon bacterial inhibition by beta-2-thienylalanine in defined media.

Authors:  K J Brown; D R Lines
Journal:  Aust J Exp Biol Med Sci       Date:  1978-08

10.  Experimental enteric Shigella and Vibrio infections in mice and guinea pigs.

Authors:  R FRETER
Journal:  J Exp Med       Date:  1956-09-01       Impact factor: 14.307

View more
  3 in total

1.  Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host.

Authors:  Manja Barthel; Siegfried Hapfelmeier; Leticia Quintanilla-Martínez; Marcus Kremer; Manfred Rohde; Michael Hogardt; Klaus Pfeffer; Holger Rüssmann; Wolf-Dietrich Hardt
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

2.  The assay on a defined medium of the effects of beta-2-thienylalanine on the growth of anaerobic bacterial isolates from phenylketonuric patients.

Authors:  K J Brown; B V Vesey; G W Tannock; E B Bell; D R Lines; R B Elliott
Journal:  Med Microbiol Immunol       Date:  1980-02       Impact factor: 3.402

3.  Salmonella Typhimurium strain ATCC14028 requires H2-hydrogenases for growth in the gut, but not at systemic sites.

Authors:  Lisa Maier; Manja Barthel; Bärbel Stecher; Robert J Maier; John S Gunn; Wolf-Dietrich Hardt
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.